IGC Pharma's top three insider shareholders as of March 23, 2026 are Strategic Investment Fund A (Cayman Islands Registration No. Cr-359857) Bradbury (TenPercentOwner, 13.82Mn shares), Ram Mukunda (Ceo, 3.99Mn shares), Richard K Prins (Director, 1.37Mn shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| Strategic Investment Fund A (Cayman Islands Registration No. Cr-359857) Bradbury | 13,823,529 | 0 | 13 May, 2024 | |
| Ram Mukunda | Ceo | 3,992,678 | 0 | 17 Oct, 2025 |
| Richard K Prins | 1,371,251 | 0 | 20 Jan, 2026 | |
| Claudia Grimaldi | Pfo | 1,134,252 | 0 | 21 Oct, 2025 |
| James P Moran | 0 | 942,402 | 26 Sep, 2024 | |
| Ram Mukunda | Ceo | 0 | 860,752 | 04 Feb, 2026 |
| James P Moran | 354,167 | 0 | 15 Mar, 2024 | |
| Rohit Goel | Senior Director Of Financepao | 235,000 | 0 | 18 May, 2021 |
| John Edward Lynch | 134,401 | 0 | 28 Jun, 2022 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 03 Feb, 2026 | Ram Mukunda | Common Stock | A | 50,000 | $0.00 | 860,752 | I | M |
| 03 Feb, 2026 | Ram Mukunda | Restricted Stock Units | A | 16,667 | $0.00 | 16,667 | I | A |
| 03 Feb, 2026 | Ram Mukunda | Restricted Stock Units | A | 66,666 | $0.00 | 66,666 | I | A |
| 19 Jan, 2026 | Richard K Prins | Common Stock | A | 100,000 | $0.00 | 1,371,251 | D | M |
| 19 Jan, 2026 | Richard K Prins | Restricted Stock Units | D | 100,000 | $0.00 | 50,000 | D | M |
| 17 Oct, 2025 | Richard K Prins | Options | A | 750,000 | $0.00 | 750,000 | D | A |
| 17 Oct, 2025 | Claudia Grimaldi | Common Stock | D | 50,000 | $0.00 | 1,134,252 | D | G |
| 17 Oct, 2025 | Terry L Lierman | Options | A | 500,000 | $0.00 | 500,000 | D | A |
| 17 Oct, 2025 | James P Moran | Options | A | 500,000 | $0.00 | 500,000 | D | A |
| 17 Oct, 2025 | Claudia Grimaldi | Options | A | 1,000,000 | $0.00 | 1,000,000 | D | A |
| 17 Oct, 2025 | Claudia Grimaldi | Options | A | 500,000 | $0.00 | 500,000 | D | A |
| 17 Oct, 2025 | Ram Mukunda | Common Stock | D | 100,000 | $0.00 | 3,992,678 | D | G |
| 17 Oct, 2025 | Ram Mukunda | Options | A | 3,000,000 | $0.00 | 3,000,000 | D | A |
| 17 Oct, 2025 | Ram Mukunda | Options | A | 1,500,000 | $0.00 | 1,500,000 | D | A |
| 25 Sep, 2024 | James P Moran | Common Stock | A | 588,235 | $0.34 | 942,402 | I | P |
| 12 Aug, 2024 | Richard K Prins | Common Stock | D | 200,000 | $0.00 | 1,042,917 | D | G |
| 22 Mar, 2024 | Strategic Investment Fund A (Cayman Islands Registration No. Cr-359857) Bradbury | COMMON STOCK | A | 8,823,529 | $0.34 | 13,823,529 | D | A |
| 13 Mar, 2024 | Ram Mukunda | Common Stock | A | 333,333 | $0.00 | 2,908,093 | D | M |
| 13 Mar, 2024 | Ram Mukunda | Common Stock | A | 233,334 | $0.00 | 3,141,427 | D | M |
| 13 Mar, 2024 | Ram Mukunda | Common Stock | A | 333,334 | $0.00 | 3,474,761 | D | M |